A Prospective Study of the Persistence of Mycoplasma Pneumoniae Antibody Levels

1974 ◽  
Vol 19 (3) ◽  
pp. 129-133 ◽  
Author(s):  
G. R. Jones ◽  
Sheila M. Stewart

Sera from 13 patients with initial complement fixation (CF) titres of 160 or above, and from 5 with rising titres to Mycoplasma pneumoniae were tested at 2-monthly intervals for CF antibodies and for cold agglutinins. In an attempt to differentiate between ‘early’ and ‘late’ sera with raised titres, initial sera and those, taken 6 to 8 months later, with a CF titre of 160 or above were tested by the metabolic inhibition test and also treated with 2-mercaptoethanol (2ME). Cold agglutinins were detected in 5 of the 13 initial sera but in none of the 7 ‘late’ sera with raised CF titres. A 4-fold or greater fall in the CF titre after treatment with 2ME occurred in 5 of the 12 initial sera tested, and in one of the 7 ‘late’ sera. Metabolic inhibiting antibodies were present in 7 of the 12 initial sera and in 4 of the 6 ‘late’ sera tested. In only one patient with a raised initial CF titre but no cold agglutinins and no 2ME effect was there later evidence of a current infection with M. pneumoniae. Cold agglutinins were present and/or there was a 2ME effect in the initial sera from all 5 patients with rising titres. It is concluded that a combination of cold agglutinins and the effect of 2ME on the CF titres will help to differentiate ‘early’ from ‘late’ sera with significantly raised CF antibodies.

1969 ◽  
Vol 67 (2) ◽  
pp. 193-208 ◽  
Author(s):  
R. F. W. Goodwin ◽  
Ruth G. Hodgson ◽  
P. Whittlestone ◽  
Rosemary L. Woodhams

SUMMARYHysterectomy-produced, colostrum-deprived pigs, reared in special isolation accommodation, were infected with enzootic pneumonia and later challenged with the same strain of the disease. Both the original infections and the subsequent challenges were made with intranasal inoculations of suspensions of ground pneumonic lung, but there was no evidence to suggest that any mycoplasma other than the J strain of Mycoplasma suipneumoniae was involved.Pigs that had recovered from the disease were strongly immune to challenge, in that they developed virtually no lung lesions when inoculated with lung suspensions that produced extensive lesions of enzootic pneumonia in control animals. This was the case, even when the pigs were as young as 16 days old when first infected and were not challenged until up to 60 weeks later.Sera from these pigs taken before infection, about 2–3 weeks after infection, at various times after natural recovery, and before and after challenge were examined using the metabolic-inhibition test, the indirect-haemagglutination test and the complement-fixation test.The metabolic-inhibition test proved of little value, because non-specific inhibitory substances were present in the sera of some pigs both before and after infection: these substances inhibited the growth of Mycoplasma hyorhinis, Mycoplasma pneumoniae and Mycoplasma gallisepticum as effectively as M. suipneumoniae. Sometimes the non-specific inhibition was reduced by heating the sera at 56° C. for 30 min., but at other times it was not, which suggests that at least two types of non-specific inhibitors were present.Apart from one pig, all the sera that were expected to be negative for antibodies against M. suipneumoniae proved to be so by the indirect-haemagglutination test. Titres of less than 1/5 were obtained in this test using the sera from pigs killed 12–22 days after infection, but high titres were obtained 16–60 weeks after infection. It was not possible to say whether these titres correlated with immunity.All the pre-infection sera when examined by the complement-fixation test had titres of less than 1/10, but by 12–22 days after infection over half the serum samples had titres of 1/40 or more, and titres of 1/80–1/640 were obtained at 4 and 9 months after infection. There was some evidence to show that these titres declined more rapidly than the titres obtained in the indirect-haemagglutination test; for they were very low at 60 weeks after infection, at which time the indirect-haemagglutination titres were still high.It seemed, therefore, that these two serological tests were measuring different aspects of the post-infection response. Also, because the complement-fixation titres were very low in two pigs that were shown to be powerfully immune, these titres did not appear to correlate with immunity.Our work with the metabolic-inhibition test and the complement-fixation test has benefited from discussions with Dr D. Taylor-Robinson and Mr A. S. Wallis, respectively. We are grateful to Drs H. P. Chu, R. H. Leach and D. Taylor-Robinson for the reference sera and the culture mentioned in the text. Most of the expenses of this work, including the salary of two of the authors (R. G.H. and R.L.W.), were met by a grant from the Agricultural Research Council.


2019 ◽  
Vol 65 (3) ◽  
pp. 97-102
Author(s):  
Maximilian Cosma Gliga ◽  
Ionela Maria Pascanu ◽  
Camelia Gliga ◽  
Ancuta Elena Zahan ◽  
Iulian Merlan

AbstractObjective: The purpose of this study was to investigate the benefits of two different Selenium based supplements on patients with chronic autoimmune thyroiditis.Methods: We conducted a prospective study on 50 patients with chronic autoimmune thyroiditis, who were divided into three different treatment groups, one group taking Selenium 100 μg, one Procor T (a combination of Selenium 100 μg and other elements like copper, Zinc and Q10 Conenzyme) and one control group taking Placebo pills. We measured on two follow up visits the antibody levels (anti-thyroidperoxidase- TPO Ab) and offered each patient a standardised questionnaire regarding the thyroid-related quality of life (THYPROro).Results: At the 6 months follow up visit there was a statistically significant decrease in the antibody levels for each treatment group compared to the base levels. The THYPROro questionnaire scores showed an improvement in most aspects regarding the quality of life as well, but there was no significant difference between the placebo and the treated groups in the magnitude of this improvement.Conclusions: Based on our results, we could not identify a certain benefit in improving quality of life with the supplementation of Selenium, as the improvements were at a similar level for the patients who took Placebo pills. Further studies with more patients, as well as taking the Selenium defficiency in consideration (by measuring the basal serum level of Selenium for each patient) would be required to find the target group of patients who could have most benefits of Selenium-based supplementation.


2013 ◽  
Vol 66 (1) ◽  
pp. 17-21 ◽  
Author(s):  
Ippei Watanabe ◽  
Kentaro Yamada ◽  
Akira Aso ◽  
Okio Suda ◽  
Takashi Matsumoto ◽  
...  

2000 ◽  
Vol 7 (5) ◽  
pp. 778-780 ◽  
Author(s):  
W. Lanier Thacker ◽  
Deborah F. Talkington

ABSTRACT The Meridian ImmunoCard (IC), GenBio ImmunoWELL-IgM, and Remel EIA commercial antibody tests are qualitative enzyme immunoassays that detect antibodies to Mycoplasma pneumoniae in serum. These tests were compared to an M. pneumoniae complement fixation (CF) assay, which uses a commercially available antigen component. The Meridian IC and the ImmunoWELL-IgM detect immunoglobulin M (IgM) only; the Remel EIA and the CF test detect both IgM and IgG antibodies. Detection of specific IgM antibody, which appears early in infection, can be, but is not always, indicative of a recent or current infection. Paired serum samples from 64 adult patients with probable M. pneumoniae infection were examined with each of the four tests. Thirty (47%) of the 64 acute-phase sera were IgM positive by Meridian IC, 26 (41%) were positive by Remel EIA, 24 (38%) were positive by CF, and 15 (23%) were positive by ImmunoWELL-IgM. When both the acute- and convalescent-phase serum samples from each patient were examined, 61 (95%) of the 64 patients were positive by CF, 60 patients (94%) were positive by Remel EIA, 52 patients (81%) were IgM positive by the Meridian IC, and 29 patients (45%) were IgM positive by the ImmunoWELL-IgM assay. The Meridian IC was more sensitive than the other tests for early detection of IgM antibodies. However, after examining paired serum samples, we concluded that the detection of IgM alone may not be useful for all cases of mycoplasma infection, especially in an adult population.


Sign in / Sign up

Export Citation Format

Share Document